RAC 2.92% $1.94 race oncology ltd

Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing, page-63

  1. 2,558 Posts.
    lightbulb Created with Sketch. 616
    Are any of the other drug combo trials in that list aiming at solid tumours or just AML? This would set us apart if we were the only one to cover the whole sha bang.
    Last edited by HeyLine: 15/05/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.